Show simple item record

The development of a regional referral pathway for locally recurrent rectal cancer: A Delphi consensus study

dc.rights.licenseopenen_US
dc.contributor.authorDENOST, Q.
dc.contributor.authorBOUSSER, V.
dc.contributor.authorMORIN-PORCHET, C.
dc.contributor.authorVINCENT, C.
dc.contributor.authorPINON, E.
dc.contributor.authorCOLLIN, F.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorMARTIN, Aurélie
dc.contributor.authorCOLOMBANI, F.
dc.contributor.authorDIGUE, L.
dc.contributor.authorRAVAUD, A.
dc.contributor.authorHARJI, D. P.
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorSAILLOUR-GLENISSON, Florence
dc.date.accessioned2021-01-21T10:43:30Z
dc.date.available2021-01-21T10:43:30Z
dc.date.issued2020
dc.identifier.issn1532-2157 (Electronic) 0748-7983 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/25941
dc.description.abstractEnBackground The management of patients with locally recurrent rectal cancer (LRRC) is often complex and requires multidisciplinary input whereas only few patients are referred to a specialist centre. The aim of this study was to design a regional referral pathway for LRRC, in Nouvelle Aquitaine (South-West, France). Methods In 2016, we conducted with a Study Steering Committee (SC) a three phase mixed-methods study including identification of key factors, identification of key stakeholders and Delphi voting consensus. During three rounds of Delphi voting, a consensus was defined as favorable, if at least 80% of participating experts rate the factor, below or equal to 3/10 using a Likert scale, or consider it as “useful” using a binary scale (third round only). Finally, the SC drafted guidelines. Results Among the 423 physicians involved in 29 regional digestive Multi-Disciplinary Team (MDT) meeting, 59 participants (from 26 MDT meeting) completed all three rounds of Delphi voting. Thirteen out of twenty initially selected factors reached a favorable consensus. All patients with a LRRC need to be included into a referral pathway. Patients with a central pelvic recurrence offered curative treatment in their local hospital and patients with unresectable metastatic disease were excluded of the referral. Key performance indicators were also agreed including the time to referral and completion of pelvic MRI-, CT-, PET-scan prior to MDT referral. Conclusion The development of this referral pathway represents an innovative health service, which will improve the management of patients with LRRC in France.
dc.language.isoENen_US
dc.subjectEMOS
dc.title.enThe development of a regional referral pathway for locally recurrent rectal cancer: A Delphi consensus study
dc.title.alternativeEur J Surg Oncolen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1016/j.ejso.2019.12.001en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed31866109en_US
bordeaux.journalEJSO - European Journal of Surgical Oncologyen_US
bordeaux.page470-475en_US
bordeaux.volume46en_US
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - U1219en_US
bordeaux.issue3en_US
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.teamEMOSen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-03117509
hal.version1
hal.date.transferred2021-01-21T10:43:34Z
hal.exporttrue
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=EJSO%20-%20European%20Journal%20of%20Surgical%20Oncology&rft.date=2020&rft.volume=46&rft.issue=3&rft.spage=470-475&rft.epage=470-475&rft.eissn=1532-2157%20(Electronic)%200748-7983%20(Linking)&rft.issn=1532-2157%20(Electronic)%200748-7983%20(Linking)&rft.au=DENOST,%20Q.&BOUSSER,%20V.&MORIN-PORCHET,%20C.&VINCENT,%20C.&PINON,%20E.&rft.genre=article


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record